Where does Genomenon's cap table come from?

Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Genomenon's 4 recorded funding rounds.

Premier Alternatives

Genomenon

Ann Arbor, MI · Founded 2014 · Privately Held (backing)

Developer of genome interpretation software designed to improve cancer diagnosis and treatment. Genomenon is based in Ann Arbor, MI and was founded in 2014. Its last known valuation is $68 million. It has raised $36.8 million across 4 recorded rounds; the latest was a $5.5 million early-stage round in May 2024.

Last price · $/share

—

Implied valuation

$68.0M

Total raised

$36.8M

Last round

Early Stage VC

May 2024

Cap table — not yet on record

Genomenon's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.

Pro members can request priority coverage with a 48-hour turnaround.

Free account

More of Genomenon with a free account

·The complete investor list: 25 names
·Watch Genomenon: the Monday email on marks, rounds and moves

Create free account

No card required

Membership and data by Private Market View

Frequently asked about Genomenon

Where does Genomenon's cap table come from?: Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Genomenon's 4 recorded funding rounds.